Amgen to build new assembly and final packaging facility in Ohio
Greenfield construction of the new facility is expected to start later this year
Amgen will spend $365 million to build a new assembly and final packaging manufacturing facility in New Albany, Ohio, the biotech has announced.
The investment — in land acquisition, building construction and manufacturing equipment — will create what the company says will be its most advanced assembly and final product packaging capabilities for medicines to be distributed in the US.
Upon completion of the 270,000-sq. ft facility, the company expects to create 400 new jobs, hiring technicians, engineers, quality assurance, quality control, administrative and management positions, with a projected annual payroll of approximately $40 million.
Amgen Executive Vice President of Operations, Esteban Santos, said the expansion, which includes some of the company's "most advanced digital automation technologies" reflects the "anticipated growth in demand for Amgen medicines".
The decision to build the facility in New Albany (approximately 15 miles northeast of Columbus) centered on the location's vibrant business environment, growing talent pool, favourable operating costs and its central location from a logistics perspective.
In addition to being built in accordance with Amgen's goal of achieving carbon neutrality by 2027, the facility also will support the company's participation as a founding member of OneTen, a coalition of many of companies that aims collectively to hire one million Black Americans into well-paying jobs during the next 10 years, with a specific focus on those without a 4-year college degree.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance